These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2003288)

  • 1. Clentiazem reduces infarct size in rabbit middle cerebral artery occlusion.
    Kaminow L; Bevan J
    Stroke; 1991 Feb; 22(2):242-6. PubMed ID: 2003288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clentiazem protects against chronic cerebral vasospasm in rabbit basilar artery.
    Vorkapic P; Bevan JA; Bevan RD
    Stroke; 1991 Nov; 22(11):1409-13. PubMed ID: 1750049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of clentiazem on cerebral ischemia induced by carotid artery occlusion in stroke-prone spontaneously hypertensive rats.
    Kikkawa K; Yamauchi R; Suzuki T; Banno K; Murata S; Tetsuka T; Nagao T
    Stroke; 1994 Feb; 25(2):474-80. PubMed ID: 8303759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of clentiazem on human coronary artery and myocardium.
    Narita H; Zera PH; Ginsburg R
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1097-104. PubMed ID: 2083194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro study of the effect of clentiazem on rabbit aorta and on myocardium.
    Narita H; Ginsburg R
    Cardiovasc Drugs Ther; 1990 Jun; 4(3):723-30. PubMed ID: 2076383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of TA-3090 (8-chloro diltiazem) related to its cerebrovascular protective properties.
    Bevan JA; Kaminow L; Laher I; Thompson LP
    Circulation; 1989 Dec; 80(6 Suppl):IV178-83. PubMed ID: 2598453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative cardiovascular actions of clentiazem, diltiazem, verapamil, nifedipine, and nimodipine in isolated rabbit tissues.
    Mecca TE; Love SD
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):678-82. PubMed ID: 1280727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a new calcium antagonist, TA3090 (clentiazem), on experimental transient focal cerebral ischemia in cats.
    Sakaki T; Tsujimoto S; Sasaoka Y; Tsunoda S; Shintomi K
    Stroke; 1993 Jun; 24(6):872-8; discussion 879. PubMed ID: 8506559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trandolapril reduces infarction area after middle cerebral artery occlusion in rats.
    Okamoto K; Takai S; Sasaki S; Miyazaki M
    Hypertens Res; 2002 Jul; 25(4):583-8. PubMed ID: 12358145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methionine sulfoximine reduces cortical infarct size in rats after middle cerebral artery occlusion.
    Swanson RA; Shiraishi K; Morton MT; Sharp FR
    Stroke; 1990 Feb; 21(2):322-7. PubMed ID: 2305410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clentiazem given at reperfusion improves subendocardial reflow and reduces myocardial infarct size in the dog.
    Rousseau G; Provost P; Tran D; Caillé G; Latour JG
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1252-60. PubMed ID: 8138938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained myocardial protection by clentiazem (TA-3090) after a 90-minute coronary occlusion and 72 hours of reperfusion in dogs with collateral flow.
    Rousseau G; Provost P; Latour JG
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):264-72. PubMed ID: 7692168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats.
    Yao H; Ibayashi S; Nakane H; Cai H; Uchimura H; Fujishima M
    Brain Res; 1997 Apr; 753(1):80-5. PubMed ID: 9125434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of a competitive NMDA antagonist MDL-100,453 reduces infarct size after permanent middle cerebral artery occlusion in rat.
    Jiang N; Zhang RL; Baron BM; Chopp M
    J Neurol Sci; 1996 Jun; 138(1-2):36-41. PubMed ID: 8791236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nimodipine on infarct size and cerebral acidosis after middle cerebral artery occlusion in the rat.
    Bielenberg GW; Burniol M; Rösen R; Klaus W
    Stroke; 1990 Dec; 21(12 Suppl):IV90-2. PubMed ID: 2260155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of CP101,606, a novel NR2B subunit antagonist of the N-methyl-D-aspartate receptor, on the volume of ischemic brain damage off cytotoxic brain edema after middle cerebral artery occlusion in the feline brain.
    Di X; Bullock R; Watson J; Fatouros P; Chenard B; White F; Corwin F
    Stroke; 1997 Nov; 28(11):2244-51. PubMed ID: 9368572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clentiazem and diltiazem preserve endothelium-dependent relaxation following global rat heart ischemia.
    Dagenais F; Hollmann C; Buluran J; Cartier R
    Can J Cardiol; 1995 Oct; 11(9):816-22. PubMed ID: 7585280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incomplete infarct and delayed neuronal death after transient middle cerebral artery occlusion in rats.
    Garcia JH; Liu KF; Ye ZR; Gutierrez JA
    Stroke; 1997 Nov; 28(11):2303-9; discussion 2310. PubMed ID: 9368580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term beneficial effects of BW619C89 on neurological deficit, cognitive deficit and brain damage after middle cerebral artery occlusion in the rat.
    Smith SE; Hodges H; Sowinski P; Man CM; Leach MJ; Sinden JD; Gray JA; Meldrum BS
    Neuroscience; 1997 Apr; 77(4):1123-35. PubMed ID: 9130792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the prostacyclin analogue, iloprost, on infarct size after permanent focal cerebral ischemia.
    Dogan A; Temiz C; Türker RK; Egemen N; Başkaya MK
    Gen Pharmacol; 1996 Oct; 27(7):1163-6. PubMed ID: 8981062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.